These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38172711)

  • 1. The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy.
    Tang LQ; Wang W; Tang QF; Wang LL
    BMC Cardiovasc Disord; 2024 Jan; 24(1):18. PubMed ID: 38172711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-146a-5p regulates autophagy and NLRP3 inflammasome activation in epithelial barrier damage in the in vitro cell model of ulcerative colitis through the RNF8/Notch1/mTORC1 pathway.
    Chen Z; Gu Q; Chen R
    Immunobiology; 2023 Jul; 228(4):152386. PubMed ID: 37329823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS.
    Xu J; Chen X; Nie W
    Shock; 2022 Aug; 58(2):147-157. PubMed ID: 35953459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.
    Shi H; Li H; Zhang F; Xue H; Zhang Y; Han Q
    Cell Biol Int; 2021 Nov; 45(11):2357-2367. PubMed ID: 34370360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of autophagy inhibits nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation and attenuates myocardial ischemia-reperfusion injury in diabetic rats.
    Zhang D; He Y; Ye X; Cai Y; Xu J; Zhang L; Li M; Liu H; Wang S; Xia Z
    J Diabetes Investig; 2020 Sep; 11(5):1126-1136. PubMed ID: 32064785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [miR-99b-5p inhibits the activation of NLRP3 inflammasome to alleviate the neurotoxicity induced by paclitaxel chemotherapy].
    Zeng WY; Gu WY; Xyu L; Zhang Y; Han C
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(5):438-442. PubMed ID: 37088748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats.
    Chen D; Dixon BJ; Doycheva DM; Li B; Zhang Y; Hu Q; He Y; Guo Z; Nowrangi D; Flores J; Filippov V; Zhang JH; Tang J
    J Neuroinflammation; 2018 Feb; 15(1):32. PubMed ID: 29394934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-26a-5p inhibits GSK3β expression and promotes cardiac hypertrophy in vitro.
    Tang L; Xie J; Yu X; Zheng Y
    PeerJ; 2020; 8():e10371. PubMed ID: 33240671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-155-5p/FOXO3a promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome activation.
    Wu L; Pu L; Zhuang Z
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):257-267. PubMed ID: 35997271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-129-5p Protects H9c2 Cardiac Myoblasts From Hypoxia/Reoxygenation Injury by Targeting TRPM7 and Inhibiting NLRP3 Inflammasome Activation.
    Liu S; Liao Q; Xu W; Zhang Z; Yin M; Cao X
    J Cardiovasc Pharmacol; 2021 May; 77(5):586-593. PubMed ID: 33951695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arctigenin mitigates vascular endothelial injury in rats with pregnancy-induced hypertension via autophagy-NLRP3 inflammasome pathway].
    Kong Q; Wang H; Ni FY
    Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3022-3031. PubMed ID: 37381960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of miR-126 in hypoxia-reoxygenation-induced cardiomyocyte pyroptosis by regulating HMGB1 and NLRP3 inflammasome.
    Fei L; Zhang N; Zhang J
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):500-509. PubMed ID: 35297734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome.
    He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z
    Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
    Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy.
    Pan W; Zhong Y; Cheng C; Liu B; Wang L; Li A; Xiong L; Liu S
    PLoS One; 2013; 8(1):e53950. PubMed ID: 23326547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-762 modulates thyroxine-induced cardiomyocyte hypertrophy by inhibiting Beclin-1.
    Qiang Z; Jin B; Peng Y; Zhang Y; Wang J; Chen C; Wang X; Liu F
    Endocrine; 2019 Dec; 66(3):585-595. PubMed ID: 31522342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Higashikuni Y; Liu W; Numata G; Tanaka K; Fukuda D; Tanaka Y; Hirata Y; Imamura T; Takimoto E; Komuro I; Sata M
    Circulation; 2023 Jan; 147(4):338-355. PubMed ID: 36440584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effects of miR-423-5p against polarization of microglial cells of the M1 phenotype by targeting a NLRP3 inflammasome signaling pathway.
    Cheng J; Hao J; Jiang X; Ji J; Wu T; Chen X; Zhang F
    Int Immunopharmacol; 2021 Oct; 99():108006. PubMed ID: 34339965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA KCNQ1OT1 as a miR-26a-5p sponge regulates ATG12-mediated cardiomyocyte autophagy and aggravates myocardial infarction.
    Li J; Tong Y; Zhou Y; Han Z; Wang X; Ding T; Qu Y; Zhang Z; Chang C; Zhang X; Qiu C
    Int J Cardiol; 2021 Sep; 338():14-23. PubMed ID: 34089766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.